Long post incoming, sorry. Following up on my initial IDC diagnosis — ER+ (99%) PR+ (96%) HER2-. Grade 2 tumor. Premenopausal (40F). Prognostic stage 1B or 2A per the MO, but leaning 2A. One 1.9cm mass and at least one axillary node confirmed positive from biopsy (three additional nodes noted to be suspicious on initial mammogram & ultrasound). Bone, CT, PET scans all clear. Genetic counseling appt on Thursday, breast MRI on Sunday. I also signed a consent form for a possible trial for HR++- patients that will include a MammaPrint test to see if I qualify (the test group gets immunotherapy in addition to standard of care chemo if determined to be high risk on MammaPrint). If I come back low risk, I have options for other trials.
I met with my medical oncologist, surgical oncologist, and nurse navigator yesterday. They seem great. The tumor board reviewed my case, and I was a bit surprised to learn that they’re learning surgery first if I pass on the trial I mentioned above. This is a bit of a change from my intake appointment with a nurse practitioner, which led me to believe chemo would be first. Both the MO and SO feel confident that with my relative health and extremely fatty breasts making it easy to pinpoint my mass, they could get clean margins on surgery (I am leaning lumpectomy with sentinel node biopsy) and believe neoadjuvant chemo wouldn’t have a significant impact on shrinking the tumor. If they find only 1-3 nodes are affected, I could avoid chemo and go straight to radiation and endocrine therapy. Of course, if the sentinel biopsy definitely shows spread, they will go back for axillary dissection — thus why the surgical oncologist sees my case as “complicated but treatable” since we'd be looking at two potential surgeries. Considering my recon options, too, if mastectomy is recommended.
Does this sound right? I’m already seeking a second opinion, but I assumed that being premenopausal with node involvement would send me straight to neoadjuvant chemo. Of course, I’d love a chance to avoid chemo, but I also want to zap any cells floating around the body and prevent recurrence! And I fully know my treatment plan, staging, etc, can change at any time based on what comes back from genetics and surgery.
If you were in my shoes, would you choose lumpectomy surgery first? SMX? DMX? Did your team push for surgery first before other treatments? FWIW, I know the MO has direct expertise in trials treating early-stage HR+ HER2- cancers in low-risk, "older" premenopausal women (40-60)—showing good evidence that surgery, rads, and endocrine therapy alone can be a highly effective treatment strategy.